Affimed Shifts Attention To Risky Combination Therapy With NK Cells For T-Cell Lymphoma
Seeking Alpha,
Follow Summary Affimed has decided to focus on testing AFM13 in combination with Artiva's AB-101 NK cell product for the…
Follow Summary Affimed has decided to focus on testing AFM13 in combination with Artiva's AB-101 NK cell product for the…
16:00 Der Strahlentherapeut personalisiert die Therapie bereits im Rahmen der anatomischen Dosisverteilung.